Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goldhirsch

Showing results (441-450 of 753) with videos related to

Pageof 76
Sort By:
The Cancer Journal From Scientific American|July 1, 1995
Adjuvant chemotherapy for premenopausal breast cancer: a meta-analysis using quality-adjusted survivalR D Gelber, B F Cole, A Goldhirsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2012
"The only thing I know is that I know nothing": 5-fluorouracil in human milkF A Peccatori, E Giovannetti, B Pistilli, et al.
The Breast Journal|September 30, 2008
Role of endocrine responsiveness and HER2/neu overexpression in inflammatory breast cancer treated with multimodality preoperative therapyClaudia D'Alessandro, Silvia Dellapasqua, Laura Orlando, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1990
c-erbB-2 protein expression in node negative breast cancerJ Richner, H A Gerber, G W Locher, et al.
The Breast Journal|July 26, 2012
Oral metronomic cyclophosphamide and methotrexate plus fulvestrant in advanced breast cancer patients: a mono-institutional case-cohort reportGaetano Aurilio, Elisabetta Munzone, Edoardo Botteri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2012
Outcome and clinical-biological characteristics of patients with advanced breast cancer undergoing removal of ovarian/pelvic metastasesE Munzone, E Botteri, A Esposito, et al.
Psycho-Oncology|October 15, 2013
The choice of whether to participate in a phase I clinical trial: increasing the awareness of patients with cancer. An exploratory studyC Catania, D Radice, G Spitaleri, et al.
Breast (Edinburgh, Scotland)|October 5, 2013
Pathological features and survival outcomes of very young patients with early breast cancer: how much is "very young"?Giuseppe Cancello, Patrick Maisonneuve, Manuelita Mazza, et al.
Anticancer Research|March 26, 2002
Chemotherapy with vinorelbine, cisplatin and continuous infusion of 5-fluorouracil in locally advanced breast cancer: a promising low-toxic regimenL Orlando, M Colleoni, G Curigliano, et al.
Lancet (London, England)|June 18, 2013
Tamoxifen therapy for patients with breast cancerPatrick Neven, Heikki Joensuu, Heikki Joenssu, et al.
Pageof 76

Showing results (441-450 of 753) with videos related to

Sort By:
Pageof 76
The Cancer Journal From Scientific American|July 1, 1995
Adjuvant chemotherapy for premenopausal breast cancer: a meta-analysis using quality-adjusted survivalR D Gelber, B F Cole, A Goldhirsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2012
"The only thing I know is that I know nothing": 5-fluorouracil in human milkF A Peccatori, E Giovannetti, B Pistilli, et al.
The Breast Journal|September 30, 2008
Role of endocrine responsiveness and HER2/neu overexpression in inflammatory breast cancer treated with multimodality preoperative therapyClaudia D'Alessandro, Silvia Dellapasqua, Laura Orlando, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1990
c-erbB-2 protein expression in node negative breast cancerJ Richner, H A Gerber, G W Locher, et al.
The Breast Journal|July 26, 2012
Oral metronomic cyclophosphamide and methotrexate plus fulvestrant in advanced breast cancer patients: a mono-institutional case-cohort reportGaetano Aurilio, Elisabetta Munzone, Edoardo Botteri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2012
Outcome and clinical-biological characteristics of patients with advanced breast cancer undergoing removal of ovarian/pelvic metastasesE Munzone, E Botteri, A Esposito, et al.
Psycho-Oncology|October 15, 2013
The choice of whether to participate in a phase I clinical trial: increasing the awareness of patients with cancer. An exploratory studyC Catania, D Radice, G Spitaleri, et al.
Breast (Edinburgh, Scotland)|October 5, 2013
Pathological features and survival outcomes of very young patients with early breast cancer: how much is "very young"?Giuseppe Cancello, Patrick Maisonneuve, Manuelita Mazza, et al.
Anticancer Research|March 26, 2002
Chemotherapy with vinorelbine, cisplatin and continuous infusion of 5-fluorouracil in locally advanced breast cancer: a promising low-toxic regimenL Orlando, M Colleoni, G Curigliano, et al.
Lancet (London, England)|June 18, 2013
Tamoxifen therapy for patients with breast cancerPatrick Neven, Heikki Joensuu, Heikki Joenssu, et al.
Pageof 76